Tilray stock surges on U.S. cannabis hype, but I remain bearish and recommend selling after the rally, as it struggles operationally and lacks meaningful U.S. cannabis exposure. Read on.
Tilray: Sell The U.S. Rescheduling Rally (NASDAQ:TLRY)
Seeking Alpha Stock3 hrs ago
45
Reuters US Economy
Santa Maria Times Local
Fast Company
CBS News
The Daily Sentinel
The Times of Northwest Indiana
Reuters US Business
The Motley Fool
CNN